Date日期
|
Time时间
|
Content议程
|
Wednesday
星期三
June 27
6月27日
|
|
Day
2, Morning Session/第二天上午
|
Venue
地点
Co-Chairs
主持
|
D308 Hall, 2nd Floor, Tianjin Binhai International
Convention & Exhibition Center
天津滨海国际会展中心二层D308厅
Junzhi WANG, Vice President, National
Institute for the Control of Pharmaceutical and Biological Products
王军志，中国药品生物制品检定所所长，副所长
Joy A CAVAGNARO, Access Bio Corp
Joy A CAVAGNARO, 美国Access Bio公司
|
08:30-09:00
|
Speaker: Joy
A CAVAGNARO, Access Bio Corp
Title: Preclinical Safety Evaluation of
Biopharmaceuticals-A Science-Based Approach to Facilitating Clinical Trials t
报告人：Joy
A CAVAGNARO 美国Access Bio公司
题 目：生物制品的临床前安全评价－一种推进临床试验的科学方法
|
09:00-09:30
|
Speaker: Li Chen, Chief
Scientific Officer and Head of Research, Roche R&D Center (China)
Title: Drug
Discovery in
China
:
Opportunity
and Challenges in Innovation
Approach
to Facilitating Clinical Trials
报告人：陈力, 罗氏中国研发中心
题 目：中国的药物发现：创新药物的机遇与挑战
|
09:30-10:00
|
Speaker: Alekxander Paul MAZUREK, Chairman of the Department
of Drug Chemistry, Faculty of Pharmacy,School ofMedicine inWarsaw，Chairman of
the Department of Basic and Applied Pharmacy, and the Laboratory of
Theoretical Methods and Computations at the National Medicines Institute inWarsaw
Title: Current
Issues on Biological, Biotechnological and Biosimilar Drug Products in Europe
报告人：Alekxander Paul MAZUREK, 华沙医学院药学系，药物化学主任；华沙国家医药研究所，理论方法和计算实验室及基础和应用药学系主任
题 目：欧洲生物、生物技术和生物仿制药物产品的现状
|
10:00-10:30
|
Coffee
Break 茶歇
|
10:30-11:00
|
Speaker: Sanjay BATRA, Asia Pacific & Japan, Johnson & Johnson Title: Advancing Drug
Development and Approval in Asia/China
报告人：Sanjay
BATRA, 强生亚太及日本
题 目：在亚洲地区/中国的药物开发和药物审批工作进展
|
11:00-11:30
|
Speaker: Annette Jørgensen, Aarhus University Hospital, Danmark
Title: Good Clinical Practice and
researcher initiated trials
报告人：Annette Jørgensen, 丹麦Aarhus大学医院
题 目：以优良临床试验规范和优秀研究员启动的临床试验
|
12:00-13:30
|
Lunch 午餐
|
Wednesday
星期三
June 27
6月27日
|
|
Day
2, Afternoon Session/第二天下午
|
Venue
地点
Co-Chairs
主持
|
D308 Hall, 2nd Floor, Tianjin Binhai International
Convention & Exhibition Center
天津滨海国际会展中心二层D308厅
Xiao-Liang WANG, Institute of Materia Medica，Chinese Academy of Medical Sciences
& Beijing Union Medical College
王晓良, 中国医学科学院药物研究所
Hancheng ZHANG
, Principal Scientist, Drug Discovery, Johnson&Johnson Pharma R&D; Elected SAPA 2007-2008 President
Hancheng ZHANG
, 美国强生公司; 美中医药开发协会（SAPA）
|
13:30-14:00
|
Speaker: David STIRLING, Celgene Corp, USA
Title: Committed to improving the
lives of patients worldwide: Celgene's immunomodulators for cancer
报告人：David
STIRLING, 美国Celgene 公司
题 目：致力于改善全球患者的生活：Celgene肿瘤免疫调节剂
|
14:00-14:30
|
Speaker: Jun-zhi WANG, National Institute for
the Control of Pharmaceutical and Biological Products (NICPBP)
Title: Research and Application of
Key Technology for Platform of Drug Nonclinical Safety Evaluation According with International GLP Standard
报告人：王军志, 中国药品生物制品检定所
题 目：符合国际GLP规范的药物非临床安全性评价平台关键技术的研究与应用
|
14:30-15:00
|
Speaker:
Hancheng ZHANG
, Principal
Scientist, Drug Discovery, Johnson&Johnson Pharma R&D; Elected SAPA 2007-2008 President Title: Innovative Drug
Discovery – Novel Protein Kinase Inhibitors
报告人：
Hancheng ZHANG
, 美国强生公司; 美中医药开发协会（SAPA）
题 目：创新药物发现－蛋白激酶抑制剂
|
15:00-15:30
|
Coffee
Break 茶歇
|
15:30-16:00
|
Speaker: Xiao-Liang WANG, Institute of Materia Medica ，Chinese
Academy of Medical Sciences & Beijing Union Medical College
Title: Development of Novel
Anti-Cerebral Ischemic Pro-drug PHPB
报告人：王晓良, 中国医学科学院药物研究所
题 目：抗脑缺血前药PHPB的研究开发
|
16:00-16:30
|
Speaker: Guo-Wei SANG, National
Institute for the Control of harmaceutical and Biological Products (NICPBP)
Title: Safety
Evaluation of Traditional Chinese Medicine
报告人：李波, 中国药品生物制品检定所
题 目：中药的安全性评价
|
|
Dinner 晚餐
|
Tuesday
星期四
June 28
6月28日
|
|
Day
3, Morning Session/第三天上午
|
Venue
地点
Co-Chairs
主持
|
D308 Hall, 2nd Floor,
Tianjin
Binhai
International
Convention
& Exhibition
Center
天津滨海国际会展中心二层D308厅
Bao-Quan ZHU, Shanghai
Institute of Pharmaceutical Industry
朱宝泉, 上海医药工业研究院
Charles Ying WANG, Asia Pacific & Japan, Johnson &
Johnson
Charles Ying WANG, 美国强生公司
|
08:30-09:00
|
Speaker: Zhongda ZHANG, Principal Scientist, Biomol;
Elected SAPA-Greater Philadelphia Chapter 2007-2008 Presiden
Title: Target Selection for Anti-Inflammatory Drugs
报告人：Zhongda ZHANG, Biomol; 美中医药开发协会（SAPA）
题 目：抗炎药物的靶点选择
|
09:00-09:30
|
Speaker: Charles Ying WANG, PrincipalScientist,Drug Evaluation-Toxicology/ Pathology,Johnson&Johnson Pharma R&D; SAPA 2006-2007 President
Title: Exploratory IND: Toxicology
Program Design and Role in Drug Development
报告人：Charles Ying
WANG, 美国强生公司;美中医药开发协会（SAPA）
题 目：探索性IND：在毒理学实验设计及新药开发中的作用
|
09:30-10:00
|
Speaker: Kewen JIN, Shanghai BioExplorer Ltd, China
Title: Building a global standard
preclinical CRO in China
报告人：Kewen JIN, 上海BioExplorer公司
题 目：在中国建立符合全球标准的临床前CRO
|
10:00-10:30
|
Coffee
Break 茶歇
|
10:30-11:00
|
Speaker: Oscar LASKIN, VP, Celgene Corp
Title: Bridging from R to D: Translational Medicine
报告人：Oscar
LASKIN, Celgene 公司
题 目：连接药物研发的桥梁：医药翻译
|
11:00-11:30
|
Speaker: Bao-Quan ZHU, Shanghai
Institute of Pharmaceutical Industry
Title: Application of New
Technologies and New Methods to Microbial Medicine Study
报告人：朱宝泉, 上海医药工业研究院
题 目：微生物药物研究中新技术和新方法的应用
|
12:00-13:30
|
Lunch 午餐
|
Thursday
星期四
June 28
6月28日
|
|
Day
3, Afternoon Session/第三天下午
|
Venue
地点
Co-Chairs
主持
|
D308 Hall, 2nd Floor, Tianjin Binhai International
Convention & Exhibition Center
天津滨海国际会展中心二层D308厅
Jing-kang SHEN, Shanghai Institute of Materia Medica, CAS
Title: Design, Synthesis and
Biological Study of BACE1 Inhibitor for Treatment of Alzheimer’s Disease
沈竞康, 中科院上海药物所
Tsang-Bin TZENG, AstraZeneca Corp, UK
Tsang-Bin TZENG, 英国阿斯利康公司
|
13:30-14:00
|
Speaker: W. Gillies MCKENNA,
Oxford
University
Title: W. Selecting Signal Transduction
Targets for use with Ionizing Radiation
报告人：W.Gillies MCKENNA, 英国牛津大学
题 目：应用电离放射选择信号转导靶点
|
14:00-14:30
|
Speaker: Jing-kang SHEN, Shanghai Institute of Materia Medica, CAS
Title: Design, Synthesis and Biological
Study of BACE1 Inhibitor for Treatment of Alzheimer’s
Disease
报告人：沈竞康, 中科院上海药物所
题 目：抑制剂治疗阿尔茨海默病的设计、合成与生物研究
|
|
